Submission for OMB Review; Comment Request; a Process/Outcome Evaluation of Parkinson's Disease Research Centers, 29163-29164 [E6-7626]
Download as PDF
<![CDATA[
wwhite on PROD1PC61 with NOTICES
Federal Register / Vol. 71, No. 97 / Friday, May 19, 2006 / Notices
Virginia, Court of Federal Claims
Number 06–0145V
48. Sandra and Justin Meyer on behalf
of Justin Meyer, Port Arthur, Texas,
Court of Federal Claims Number
06–0148V
49. Holly and Joshua Winstead on
behalf of Jeremy Winstead, Athens,
Georgia, Court of Federal Claims
Number 06–0159V
50. Randi and Michael Bryant on behalf
of Kyle Bryant, Baldwinsville, New
York, Court of Federal Claims
Number 06–0162V
51. Tracie and Brad Childress on behalf
of Nathan Childress, Sparkill, New
York, Court of Federal Claims
Number 06–0163V
52. Linda and Daniel Moffitt on behalf
of Robert Moffitt, Orangeburg, New
York, Court of Federal Claims
Number 06–0164V
53. Svitlana Budzak-Jones and Laird
Jones on behalf of William
Oleksandr Jones, State College,
Pennsylvania, Court of Federal
Claims Number 06–0165V
54. Suanne and Bradley Knutson on
behalf of Jack Bradley Knutson,
Sioux Falls, South Dakota, Court of
Federal Claims Number 06–0166V
55. Debra Ann Anderson, Sioux Falls,
South Dakota, Court of Federal
Claims Number 06–0168V
56. Anita Reino on behalf of Angela
Reino, Thonotosassa, Florida, Court
of Federal Claims Number 06–
0170V
57. Meghan Bramlage on behalf of
Mitchell Bramlage, Boston,
Massachusetts, Court of Federal
Claims Number 06–0171V
58. Jolee Carney on behalf of Jordan
Custer, Deceased, Ellsworth,
Washington, Court of Federal
Claims Number 06–0187V
59. Sarah and Christopher Hoiberg on
behalf of Caitlyn Joy Hoiberg,
Jacksonville, Florida, Court of
Federal Claims Number 06–0188V
60. Tamar Feld, Englewood, New Jersey,
Court of Federal Claims Number
06–0190V
61. Louis Tosches, II on behalf of Louis
Tosches, III, Towson, Maryland,
Court of Federal Claims Number
06–0192V
62. Jessica Kuttner on behalf of Calvin
Kuttner, Traverse City, Michigan,
Court of Federal Claims Number
06–0195V
63. Stephanie Coleman on behalf of
Lincoln Coleman, Boston,
Massachusetts, Court of Federal
Claims Number 06–0197V
64. James Robert Dickman on behalf of
Lindsay Kathleen Dickman,
Deceased, New York, New York,
Court of Federal Claims Number
06–0199V
VerDate Aug<31>2005
17:37 May 18, 2006
Jkt 208001
65. Roberta and Ronald Moore on behalf
of Daniel Moore, Tampa, Florida,
Court of Federal Claims Number
06–0200V
66. Patricia and Vincent Miller on
behalf of John Miller, West Orange,
New Jersey, Court of Federal Claims
Number 06–0201V
67. Linda and Charles Veneman on
behalf of Linda Veneman,
Henderson, Nevada, Court of
Federal Claims Number 06–0203V
68. Linda and Charles Veneman on
behalf of Linda Veneman,
Henderson, Nevada, Court of
Federal Claims Number 06–0204V
69. Naomi and Emanuel Goldman on
behalf of Tamara June Goldman,
Deceased, West Orange, New Jersey,
Court of Federal Claims Number
06–0206V
70. Bethany and Randall Loudenslager
on behalf of Zachary Loudenslager,
Strongsville, Ohio, Court of Federal
Claims Number 06–0207V
71. Lee and William Hinton on behalf of
William S. Hinton, Jr., Mountain
Brook, Alabama, Court of Federal
Claims Number 06–0208V
72. Lynn and Shawn Sevey on behalf of
Shalyn Sevey, Folsom, California,
Court of Federal Claims Number
06–0209V
73. Tamara Charles on behalf of Jeron
Charles, Brooklyn, New York, Court
of Federal Claims Number 06–
0212V
74. Jaynna and Eric Moxley on behalf of
Mary Madison Moxley, Cabot,
Arkansas, Court of Federal Claims
Number 06–0213V
75. Carina Dewitt-Lord and Richard
Lord on behalf of Zachary Dylan
Lord, Philadelphia, Pennsylvania,
Court of Federal Claims Number
06–0215V
76. Lynne Paumier, Downington,
Pennsylvania, Court of Federal
Claims Number 06–0220V
77. Hilmi and Samar Amar on behalf of
Rushia Amar, Arlington, Texas,
Court of Federal Claims Number
06–0221V
78. Parivash and Saeid Mojabi on behalf
of Ryan Mojabi, San Jose,
California, Court of Federal Claims
Number 06–0227V
79. Penny and Richard Majewski on
behalf of Zachary Adam Majewski,
Somers Point, New Jersey, Court of
Federal Claims Number 06–0229V
80. Diane and Samuel Yellis on behalf
of Sophie Yellis, Lake Success, New
York, Court of Federal Claims
Number 06–0234V
81. Gayle Delong and Jonathan Rose on
behalf of Flora Rose, Morristown,
New Jersey, Court of Federal Claims
Number 06–0235V
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
29163
82. Lori and Kevin Champagne on
behalf of Jared Champagne,
Baldwinsville, New York, Court of
Federal Claims Number 06–0248V
83. Adrian Green and Nathaniel
Armstrong, Jr. on behalf of Nijieh
Green, Philadelphia, Pennsylvania,
Court of Federal Claims Number
06–0249V
84. Geetha Srinivasarao and
Cholanayakanahalli Vinayak on
behalf of Praveen Vinayak,
Washington, D.C., Court of Federal
Claims Number 06–0250V
85. Denise and James Walker on behalf
of Nicholas John Walker, East
Stroudsburg, Pennsylvania, Court of
Federal Claims Number 06–0252V
86. Rena DeFelice on behalf of Carson
DeFelice, Katy, Texas, Court of
Federal Claims Number 06–0253V
87. Heather and Adrian Aschmann on
behalf of Adrian Aschmann, Estell
Manor, New Jersey, Court of Federal
Claims Number 06–0256V
88. Daphne and John Dunstan on behalf
of William Dunstan, Philadelphia,
Pennsylvania, Court of Federal
Claims Number 06–0257V
Dated: May 15, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. E6–7665 Filed 5–18–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; a Process/
Outcome Evaluation of Parkinson’s
Disease Research Centers
SUMMARY: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institute of Neurological Disorders and
Stroke (NINDS) Office of Science Policy
and Planning, the National Institute of
Health (NIH) has submitted to the Office
of Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on December 21, 2005, pages
75823–75824, and allowed 60-days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Institutes of Health may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
E:\FR\FM\19MYN1.SGM
19MYN1
29164
Federal Register / Vol. 71, No. 97 / Friday, May 19, 2006 / Notices
October 1, 1995, unless it displays a
currently valid OMB control number.
Proposed Collection: Title: A Process/
Outcome Evaluation of Parkinson’s
Disease Research Centers Type of
Information Collection Request: NEW.
Need and Use of Information Collection:
This study is primarily an outcome
evaluation, designed to assess the extent
to which the NINDS-funded Morris K.
Udall Centers for Excellence in
Parkinson’s Disease Research have
achieved the program’s short-term and
long-term goals. The study also includes
elements of a process evaluation in its
examination of the major activities
conducted by the Udall Centers, the
relationship between Center activities
and the achievement of program goals,
and the NINDS management of the
program. The results of the full-scale
evaluation should be very helpful to
NINDS in identifying the most relevant
measures for tracking the future
progress of the Centers, developing
strategies to enhance the program’s
effectiveness, and improving program
management. NINDS will also use the
findings to inform its National Advisory
Neurological Disorders and Stroke
Council, and to address inquiries from
the public regarding the impact of the
Estimated
number of
respondents
Type of respondents
Udall Centers Program. Lastly, Udall
Center awardees will be able to use the
evaluation results to improve the
performance of their Centers; and other
NIH Institutes and Centers may use the
methodology and results of this
evaluation to guide their own centers
assessments. Frequency of Response:
Once or twice. Affected Public:
Researchers, Not-for-profit institutions;
Federal Government; individuals or
households. Type of Respondents: Adult
professionals.
The annual reporting burden is
provided in the following table:
Estimated
frequency of
response
Estimated
average time
per response
Estimated
annual hour
burden
13
54
54
2
2
1
1.5
1.5
1.0
39
162
54
Totals ........................................................................................................
wwhite on PROD1PC61 with NOTICES
Center Directors ...............................................................................................
Project/Core Directors .....................................................................................
Comparison Group ..........................................................................................
121
........................
........................
255
There are no Capital Costs to report.
There are no Operating or Maintenance
Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriated automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT:
Written comments and/or suggestions
regarding the item(s) contained in this
notice, especially regarding the
estimated public burdenand associated
response time, should be directed to the:
Office of Management and Budget,
Office of Regulatory Affairs, New
Executive Office Building, Room 10235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Dr.
Melinda Kelley, Office of Science Policy
VerDate Aug<31>2005
17:37 May 18, 2006
Jkt 208001
and Planning, National Institute of
Neurological Disorders and Stroke, NIH,
Building 31, 31 Center Drive, Room 8A–
03, Bethesda, MD 20892; call non-tollfree 301–496–9271; or E-mail your
request, including your address to:
ospp@ninds.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
Dated: May 11, 2006.
Story C. Landis,
Director, NINDS, National Institutes of
Health.
[FR Doc. E6–7626 Filed 5–18–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: (301)
496–7057; fax: (301) 402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Viral Entry or Replication Inhibition
Using siRNA, Small Molecules, or
Other Tec Tyrosine Kinase Inhibitors
Julie Readinger and Pamela L.
Schwartzberg (NHGRI).
U.S. Provisional Application filed 29
Mar 2006 (HHS Reference No. E–151–
2006/0–US–01).
Licensing Contact: Susan Ano; 301/435–
5515; anos@mail.nih.gov.
The Tec family of tyrosine kinases,
consisting of five family members Tec,
Btk, Itk, Rlk, and BMX, are key
regulators of signaling pathways of T
lymphocytes. Many existing antiviral
therapies rely on inhibition of viral
replication, which leads to emergence or
selection of resistant viruses. The
current technology provides an
alternative target for the prevention or
treatment of viral infection through
administration of a Tec tyrosine kinase
inhibitor. Such inhibitors can be siRNA,
small chemical compounds, antisense or
antibody. The current technology
describes the inhibition of Itk (also
E:\FR\FM\19MYN1.SGM
19MYN1
]]>Agencies
[Federal Register Volume 71, Number 97 (Friday, May 19, 2006)]
[Notices]
[Pages 29163-29164]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7626]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; a Process/Outcome
Evaluation of Parkinson's Disease Research Centers
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institute of Neurological Disorders
and Stroke (NINDS) Office of Science Policy and Planning, the National
Institute of Health (NIH) has submitted to the Office of Management and
Budget (OMB) a request for review and approval of the information
collection listed below. This proposed information collection was
previously published in the Federal Register on December 21, 2005,
pages 75823-75824, and allowed 60-days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. The National Institutes of
Health may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after
[[Page 29164]]
October 1, 1995, unless it displays a currently valid OMB control
number.
Proposed Collection: Title: A Process/Outcome Evaluation of
Parkinson's Disease Research Centers Type of Information Collection
Request: NEW. Need and Use of Information Collection: This study is
primarily an outcome evaluation, designed to assess the extent to which
the NINDS-funded Morris K. Udall Centers for Excellence in Parkinson's
Disease Research have achieved the program's short-term and long-term
goals. The study also includes elements of a process evaluation in its
examination of the major activities conducted by the Udall Centers, the
relationship between Center activities and the achievement of program
goals, and the NINDS management of the program. The results of the
full-scale evaluation should be very helpful to NINDS in identifying
the most relevant measures for tracking the future progress of the
Centers, developing strategies to enhance the program's effectiveness,
and improving program management. NINDS will also use the findings to
inform its National Advisory Neurological Disorders and Stroke Council,
and to address inquiries from the public regarding the impact of the
Udall Centers Program. Lastly, Udall Center awardees will be able to
use the evaluation results to improve the performance of their Centers;
and other NIH Institutes and Centers may use the methodology and
results of this evaluation to guide their own centers assessments.
Frequency of Response: Once or twice. Affected Public: Researchers,
Not-for-profit institutions; Federal Government; individuals or
households. Type of Respondents: Adult professionals.
The annual reporting burden is provided in the following table:
----------------------------------------------------------------------------------------------------------------
Estimated Estimated Estimated Estimated
Type of respondents number of frequency of average time annual hour
respondents response per response burden
----------------------------------------------------------------------------------------------------------------
Center Directors................................ 13 2 1.5 39
Project/Core Directors.......................... 54 2 1.5 162
Comparison Group................................ 54 1 1.0 54
---------------------------------------------------------------
Totals...................................... 121 .............. .............. 255
----------------------------------------------------------------------------------------------------------------
There are no Capital Costs to report. There are no Operating or
Maintenance Costs to report.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Enhance the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriated automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burdenand associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, New Executive Office Building, Room 10235, Washington, DC
20503, Attention: Desk Officer for NIH. To request more information on
the proposed project or to obtain a copy of the data collection plans
and instruments, contact: Dr. Melinda Kelley, Office of Science Policy
and Planning, National Institute of Neurological Disorders and Stroke,
NIH, Building 31, 31 Center Drive, Room 8A-03, Bethesda, MD 20892; call
non-toll-free 301-496-9271; or E-mail your request, including your
address to: ospp@ninds.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
Dated: May 11, 2006.
Story C. Landis,
Director, NINDS, National Institutes of Health.
[FR Doc. E6-7626 Filed 5-18-06; 8:45 am]
BILLING CODE 4140-01-P
